X

CJC-1295 (no DAC) 5 mg

35,00 

CJC-1295 (no DAC) is a synthetic growth hormone–releasing hormone (GHRH) analog supplied in lyophilized powder form for laboratory research. Commonly investigated in studies of pulsatile GH signaling and pituitary regulatory mechanisms. Delivered as a 5 mg sterile lyophilized preparation in a sealed research vial.

In stock

Description

Growth Hormone Releasing Hormone (GHRH) analog for research use

Product overview

CJC-1295 (no DAC) is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) designed to stimulate the natural release of growth hormone (GH) and IGF-1. The “no DAC” version features a shorter half-life, allowing for pulsatile GH secretion that more closely mimics physiological release patterns. It is widely studied in research focused on metabolic regulation, recovery, and cellular regeneration.

Key benefits (anecdotal & research-based)

Stimulates natural GH and IGF-1 release in a pulsatile manner.
Supports research related to muscle growth, recovery, and regeneration.
May promote improved sleep quality and cellular repair in animal models.
Commonly studied in combination with GHRPs (e.g., Ipamorelin) for synergistic effects.
Non-DAC form allows for precise timing and cycle-based experimental design.

Product characteristics

Purity: ≥ 98% (HPLC)
Appearance: white lyophilized powder
Molecular formula: C154H255N45O43
Molecular weight: 3424.95
Sequence: Gly-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Storage: store lyophilized powder at -20°C, protect from light and moisture. Reconstituted solution should be kept at 2–8°C and used within a short period.

Why choose our CJC-1295 (no DAC)?

≥ 98% purity verified by HPLC.
Produced in GMP-compliant facilities under strict QC protocols.
Each batch carefully lab tested after production (you can find Certificate of Analysis under product pictures).
Freeze-dried (lyophilized) for maximum stability and extended shelf life.
Sealed in sterile vials, ready for reconstitution.

Suggested use

In research settings, CJC-1295 (no DAC) is most commonly studied via subcutaneous administration.
Typical research dosage range: 100–200 mcg per administration.
Protocol frequency: 1–2 times daily, often paired with a GHRP such as Ipamorelin.
Timing in studies: commonly administered in fasting conditions or before sleep to simulate natural GH peaks.
Must be reconstituted with 2-3 ml of bacteriostatic water before use.

NOTE: This is for educational reference only and does not constitute medical advice.

Disclaimer
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 (no DAC) 5 mg”

Your email address will not be published. Required fields are marked *

Related products